ClinicalTrials.Veeva

Menu

Assessment of a New Closed-loop Algorithm in Type 1 Diabetes (Saddle Point Model Predictive Control : SP-MPC) (PPA)

R

Rennes University Hospital

Status

Completed

Conditions

Type 1 Diabetes

Treatments

Other: open-loop night
Other: closed-loop night

Study type

Interventional

Funder types

Other

Identifiers

NCT02061488
35RC13_8806_PPA (Other Identifier)
2013-A01604-41

Details and patient eligibility

About

The purpose of the study is to assess a new closed-loop algorithm in type 1 diabetes (Saddle Point Model Predictive Control : SP-MPC)

Full description

Ten patients will be assessed during a closed-loop night and an open-loop night in random order.

The primary objective is to assess the ability of SP-MPC controler to maintain euglycemia and avoid hypoglycaemia during the night, compared to open loop in type 1 diabetic patients treated by insulin pump.

Enrollment

10 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with type 1 diabetes (C peptide negative) :
  • 18 to 70 year old,
  • with type 1 diabetes for more than 3 years,
  • treated by insulin pump for more than 3 months,
  • with previous CGM holter allowing preliminary settting of some of the SP-MPC parameters
  • able to provide written informed consent.

Exclusion criteria

  • pregnancy or breastfeeding,
  • severe non stabilized diabetic retinopathy,
  • cardiovascular event in the previous 6 months,
  • infectious diseases with recent fever,
  • anemia (hemoglobin < 11g/l),
  • HbA1c > 10%,
  • Current or recent (less than 4 weeks) oral or injectable corticosteroid treatment,
  • creatinine clearance <40ml/mn,
  • chronic alcoholism (weekly consumption of alcohol > 280g for men and > 140g for women),
  • adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 2 patient groups

open-loop night
Active Comparator group
Treatment:
Other: open-loop night
closed-loop night
Experimental group
Treatment:
Other: closed-loop night

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems